Foundayo Weight Loss Results What To Expect Week By Week
What Is Foundayo and How It Affects Weight LossFoundayo is an oral GLP-1 receptor agonist that works by slowing gastric emptying and reducing appetite signals in the brain. [...]
Read More
Medically reviewed by Jerome Albert Ecker | MD, Assistant Professor of Medicine, Duke University - Durham, NC on April 16th, 2024.
Adenocarcinomas represent 30-40% of cases, but neuroendocrine tumors (35%) and gastrointestinal stromal tumors (GISTs) also commonly affect the small bowel, each requiring different treatment approaches.
Symptoms often remain silent until advanced stages—when present, intermittent cramping abdominal pain occurs in 60-70% of patients, while complete bowel obstruction develops in about 25% of cases.
Men over 60 face the highest risk, particularly those with Crohn's disease (4-33x increased risk), celiac disease, or hereditary syndromes like Lynch syndrome and Peutz-Jeghers syndrome.
Surgical resection offers the best outcomes when caught early, with 5-year survival rates reaching 65% for localized disease but dropping to 42% once it spreads to nearby lymph nodes.
CT enterography and capsule endoscopy detect lesions missed by standard colonoscopy, since the 20-foot small intestine lies beyond reach of conventional scopes used for colon screening.
Small intestine cancer, also known as small bowel cancer, is a rare disease that occurs when cells in the small intestine grow out of control and form a tumor. The small intestine is a crucial part of the digestive system, connecting the stomach to the large intestine and playing a vital role in breaking down and absorbing nutrients from food.
There are five main types of small intestine cancer:
Adenocarcinomas (30-40% of cases)
Sarcoma
Carcinoid tumors
Gastrointestinal stromal tumors (GISTs)
Intestinal lymphomas
Symptoms of small intestine cancer may include:
Pain or cramps in the middle of the stomach
Unexplained weight loss
A lump in the abdomen
Blood in the stool or black, tarry stools
Nausea or vomiting
Loss of appetite
Bloating
Anemia
Bowel obstruction (inability to pass gas or stool, severe pain, and vomiting)
If you experience any of these symptoms, it's essential to consult your doctor for a proper diagnosis.
While the exact causes of small intestine cancer are not well understood, several factors can increase your risk of developing the disease:
Age (average age at diagnosis is 60)
Gender (slightly higher risk in men)
Genetic disorders
Smoking and alcohol use
High-fat diet
Exposure to certain chemicals, such as phenoxyacetic acid
Pre-existing conditions affecting the gut (e.g., Crohn's disease, colon cancer, or celiac disease)
Lymphedema (damage to the vessels connecting to the lymph nodes)
To diagnose small intestine cancer, your doctor will perform a thorough medical exam and may order various tests, including:
Imaging tests (X-rays, CT scans, MRI)
Endoscopy
Blood chemistry tests
Liver function tests
Fecal occult blood test
Lymph node biopsy
Laparotomy (surgical procedure)
Treatment for small intestine cancer depends on the type of cancer and whether it has spread. Common treatment options include:
Surgery to remove the affected part of the small intestine or to bypass a tumor
Radiation therapy to kill cancer cells
Chemotherapy to kill cancer cells or stop their growth
Targeted therapy (everolimus, imatnib)
In addition to these standard treatments, new therapies are being tested in clinical trials. Talk to your doctor if you're interested in participating in a clinical trial before, during, or after your treatment.
For more information on small intestine cancer, visit reputable sources such as the American Cancer Society, Mayo Clinic, and the National Cancer Institute.
This rare cancer often goes undetected until advanced stages because symptoms mimic common digestive issues and the small intestine is difficult to examine with standard screening tools. Anyone experiencing persistent abdominal pain, unexplained weight loss, or recurring bowel issues—especially those with inflammatory bowel disease—should seek specialized evaluation. Doctronic can help connect you with gastroenterologists who have experience with advanced diagnostic techniques for hard-to-detect digestive cancers.
What Is Foundayo and How It Affects Weight LossFoundayo is an oral GLP-1 receptor agonist that works by slowing gastric emptying and reducing appetite signals in the brain. [...]
Read MoreWhat Is Foundayo and How Does It Affect Diabetes?Foundayo contains orforglipron, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines. [...]
Read MoreWhat Are Foundayo and Mounjaro?Foundayo (orforglipron) represents Eli Lilly's investigational oral GLP-1 receptor agonist currently in Phase 3 clinical trials. This [...]
Read More
Join 50,000+ readers using Doctronic to understand symptoms, medications,
and next steps.
Add your phone number below to get health updates and exclusive VIP offers.
By providing your phone number, you agree to receive SMS updates from Company. Message and data rates may apply. Reply “STOP” to opt-out anytime. Read our Privacy Policy and Terms of Service for more details.
Save your consults. Talk with licensed doctors and manage your health history.